Skip to content

The Influence of Different Dexmedetomidine Doses on Cognitive Function at Early Period of Patients undergoing Laparoscopic Extensive Total Hysterectomy

The Influence of Different Dexmedetomidine Doses on Cognitive Function at Early Period of Patients undergoing Laparoscopic Extensive Total Hysterectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042922
Enrollment
Unknown
Registered
2021-01-31
Start date
2021-02-22
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognition impairment

Interventions

Group A:In group A, 0.05 mg/kg midazolam was injected intravenously 10 minutes before induction, and 0.5 µg/(kg·min) midazolam was continuously pumped after tracheal intubation to 30 minutes before th
Group B:Intravenous injection of dexmedetomidine at 1ug/kg was performed before anesthesia induction for 10min. Then, the infusion was maintained at 0.2 g/(kg·h) until the infusion was stopped 30min b
Group C:Intravenous injection of dexmedetomidine at 0.5ug/kg was performed before anesthesia induction for 10min. Then, the infusion was maintained at 0.2 g/(kg·h) until the infusion was stopped 30min
Group D:Intravenous injection of dexmedetomidine at 0.25ug/kg was performed before anesthesia induction for 10min. Then, the infusion was maintained at 0.2 g/(kg·h) until the infusion was stopped 30mi

Sponsors

Women and Children's Hospital, School of Medicine, Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Estimated survival time of patients was more than 3 months, and ASA was grade I-II. 2.Patients without respiratory complications. 3.Approved by the ethics committee of this hospital, the ethics number is KY-2020-057. 4.Patients and their family members agreed and cooperated with this study, and signed an informed agreement.

Exclusion criteria

Exclusion criteria: 1. Patients have contraindication to dexmedetomidine. 2. Patients have severe heart, liver and kidney dysfunction. 3. Patients have nervous system and mental illness. 4. Patients have undergone long-term analgesia and sedation before operation. 5. Patients have contraindications to laparoscopic operation. 6. Blind or deaf people are difficult to evaluate by cognitive score. Sixth, 7. Patients have poor compliance, withdrawing halfway through.

Design outcomes

Primary

MeasureTime frame
MoCA (Montreal Cognitive Assessment Scale) score;MMSE (Simplified Mental State Scale) score;TNF- (tumor necrosis Factor -a);IL-6;S - 100 protein beta;NSE;GFAP;Intraoperative dosage of Remifentanil, sufentanil, propofol,;Resuscitation room stay time, anesthesia extubation time and anesthesia recovery time;

Countries

China

Contacts

Public ContactJunxiang Jia

Women and Children's Hospital, School of Medicine, Xiamen University

ybmzjjx@126.com+86 15980965934

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026